文献速递认知障碍与谵妄衰弱、肌少症与跌倒多重用药

养老院痴呆患者合用胆碱酯酶抑制剂与β受体阻滞剂的跌倒相关住院风险

Fall-Related Hospitalizations in Nursing Home Residents Co-Prescribed a Cholinesterase Inhibitor and Beta-Blocker.
PubMed 文献 · J Am Geriatr Soc · 2020-08-15

该巢式病例对照研究基于加拿大安大略省养老院人群数据库,纳入2013年4月至2018年3月入组后至少使用一种β受体阻滞剂的66岁以上痴呆患者共19060例。

要点

  • 痴呆养老院居民使用β受体阻滞剂时,合用胆碱酯酶抑制剂未增加跌倒相关住院风险。
  • 衰弱、年龄、性别及跌倒住院史亚组分析均未见效应修饰。

核心结论

  • 在服用β受体阻滞剂的痴呆养老院居民中,合用胆碱酯酶抑制剂与跌倒相关住院风险增加无关。

研究设计与样本

  • 巢式病例对照研究,基于加拿大安大略省所有养老院人群行政数据库。
  • 纳入2013年4月至2018年3月入组后至少使用一种β受体阻滞剂的66岁以上痴呆患者19060例。
  • 病例为因跌倒相关损伤住院(急诊就诊或急性住院)且同时使用β受体阻滞剂者3038例,按年龄(±1岁)、性别、入组年份、衰弱及跌倒相关损伤史1:1匹配对照。

主要发现

  • 90天内暴露于胆碱酯酶抑制剂者中,病例组947例(31.2%),对照组940例(30.9%)。
  • 次要暴露(药物类型、日剂量、新发与持续使用、30天内使用)及亚组分析(衰弱、年龄组、性别、跌倒住院史)结果一致。

关键数值与推荐

  • 主要暴露为跌倒相关住院前90天内胆碱酯酶抑制剂暴露。
  • 主要结局为跌倒相关损伤住院,定义为急诊就诊或急性住院。
  • 匹配因素包括年龄(±1岁)、性别、入组年份、衰弱及跌倒相关损伤史。

临床怎么用

  • 对于服用β受体阻滞剂的痴呆养老院居民,不应仅因担心跌倒相关住院而避免启动或停用胆碱酯酶抑制剂。
  • 该结果可为痴呆患者、照护者与临床医生关于胆碱酯酶抑制剂启动和/或停用的共享决策提供参考。

局限性

  • 未评估胆碱酯酶抑制剂与未导致住院的跌倒之间的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/OBJECTIVES: To examine the association between hospitalization for a fall-related injury and the co-prescription of a cholinesterase inhibitor (ChEI) among persons with dementia receiving a beta-blocker, and whether this potential drug-drug interaction is modified by frailty. DESIGN: Nested case-control study using population-based administrative databases. SETTING: All nursing homes in Ontario, Canada. PARTICIPANTS: Persons with dementia aged 66 and older who received at least one beta-blocker between April 2013 and March 2018 following nursing home admission (n = 19,060). MEASUREMENTS: Cases were persons with dementia with a hospitalization (emergency department visit or acute care admission) for a fall-related injury with concurrent beta-blocker use. Each case (n = 3,038) was matched 1:1 to a control by age (±1 year), sex, cohort entry year, frailty, and history of fall-related injuries. The association between fall-related injury and exposure to a ChEI in the 90 days prior was examined using multivariable conditional logistic regression. Secondary exposures included ChEI type, daily dose, incident versus prevalent use, and use in the prior 30 days. Subgroup analyses considered frailty, age group, sex, and history of hospitalization for fall-related injuries. RESULTS: Exposure to a ChEI in the prior 90 days occurred among 947 (31.2%) cases and 940 (30.9%) controls. In multivariable models, no association was found between hospitalization for a fall-related injury and prior exposure to a ChEI in persons with dementia dispensed beta-blockers (adjusted odds ratio = .96, 95% confidence interval = .85-1.08). Findings were consistent across secondary exposures and subgroup analyses. CONCLUSION: Among nursing home residents with dementia receiving beta-blockers, co-prescription of a ChEI was not associated with an increased risk of hospitalization for a fall-related injury. However, we did not assess for its association with falls not leading to hospitalization. This finding could inform clinical guidelines and shared decision making between persons with dementia, caregivers, and clinicians concerning ChEI initiation and/or discontinuation.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Watt JA, Campitelli MA, Maxwell CJ, et al. Fall-Related Hospitalizations in Nursing Home Residents Co-Prescribed a Cholinesterase Inhibitor and Beta-Blocker. J Am Geriatr Soc. 2020. PMID: 33460072. doi:10.1111/jgs.16710

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。